Frontiers in Microbiology (Apr 2022)

Atypical Antibody Dynamics During Human Coronavirus HKU1 Infections

  • Ferdyansyah Sechan,
  • Ferdyansyah Sechan,
  • Marloes Grobben,
  • Marloes Grobben,
  • Arthur W. D. Edridge,
  • Arthur W. D. Edridge,
  • Maarten F. Jebbink,
  • Maarten F. Jebbink,
  • Katherine Loens,
  • Katherine Loens,
  • Margareta Ieven,
  • Herman Goossens,
  • Herman Goossens,
  • Susan van Hemert-Glaubitz,
  • Marit J. van Gils,
  • Marit J. van Gils,
  • Lia van der Hoek,
  • Lia van der Hoek

DOI
https://doi.org/10.3389/fmicb.2022.853410
Journal volume & issue
Vol. 13

Abstract

Read online

Human coronavirus HKU1 (HCoV-HKU1) is one of the four endemic coronaviruses. It has been suggested that there is a difference in incidence, with PCR-confirmed HCoV-NL63 and HCoV-OC43 infections occurring more commonly, whereas HCoV-HKU1 is the least seen. Lower incidence of HCoV-HKU1 infection has also been observed in serological studies. The current study aimed to investigate antibody dynamics during PCR-confirmed HCoV-HKU1 infections using serum collected during infection and 1 month later. We expressed a new HCoV-HKU1 antigen consisting of both the linker and carboxy-terminal domain of the viral nucleocapsid protein and implemented it in ELISA. We also applied a spike-based Luminex assay on serum samples from PCR-confirmed infections by the four endemic HCoVs. At least half of HCoV-HKU1-infected subjects consistently showed no antibody rise via either assay, and some subjects even exhibited substantial antibody decline. Investigation of self-reported symptoms revealed that HCoV-HKU1-infected subjects rated their illness milder than subjects infected by other HCoVs. In conclusion, HCoV-HKU1 infections reported in this study displayed atypical antibody dynamics and milder symptoms when compared to the other endemic HCoVs.

Keywords